Derick En'Wezoh, MD
Healthcare and Tech Investor @ Susa Ventures
San Francisco Bay Area, United States
Derick En'Wezoh, MD is a seed investor at Susa Ventures in San Francisco Bay Area focused on Health Care and Artificial Intelligence. Dr. Derick En'Wezoh is an entrepreneurial physician and investor at Susa Ventures where he specializes in healthcare and technologies outside of healthcare focused on AI/ML/NLP/LLMs and workflow automation. Derick is a seasoned healthcare operator. Before joining Susa Ventures, Derick led Growth at Viz.ai, a leader in AI-drivendisease detection and care coordination, where he built several departments and was responsible for executing commercial strategies. Before Viz.ai, Derick was a surgical resident at Stanford Hospital. He completed his MD at Harvard, his MBA at Stanford, and is an alumnus of Stanford Biodesign. Derick is deeply committed to supporting entrepreneurs and investing in innovations that positively impact the lives of others.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Derick En'Wezoh, MD invests in
Stages Derick En'Wezoh, MD invests in
Countries Derick En'Wezoh, MD invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 8 (80%)
- Artificial Intelligence 6 (60%)
- Medical 4 (40%)
- Software 2 (20%)
- Machine Learning 2 (20%)
Stage
- Seed 7 (70%)
- Pre-Seed 1 (10%)
- Series A 1 (10%)
- Series B 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Grata Health
|
Grata is an AI-enabled addiction treatment platform that pairs a virtual clinic (MAT, therapy, peer support) with software to triage, schedule, and support patients in under a minute. The patient app delivers continuous recovery touchpoints, and the EHR automates provider workflows and risk monitoring to improve retention and lower cost of care. | Pre-Seed / Sep 01, 2025 | |
The Wound Company
|
The Wound Company is repairing the wound and ostomy care industry's flaws by utilizing predictive analytics and multi-channel communications to provide the appropriate wound and ostomy care to the appropriate patient in the appropriate channel at the appropriate time. | $4.3M / Seed / Jun 15, 2023 | |
Together AI
|
Together AI provides a cloud platform for developing, training, fine-tuning, and deploying generative artificial intelligence models using open-source technologies. Its services include serverless and dedicated model inference, GPU compute infrastructure, managed storage, code sandboxes, and model customization tools that support AI applicationdevelopment and production workloads. The platform also offers APIs and deployment options that enable developers and organizations to build, run, and manage language, image, audio, vision, and code models without maintaining underlying infrastructure. | $20M / Seed / May 15, 2023 | |
Nourish
|
Nourish is a healthcare technology company that connects patients with registered dietitians through virtual nutrition counseling services covered by insurance plans. The platform allows users to find dietitians based on their health goals and attend appointments through telehealth, while also offering tools for meal tracking, goal monitoring, andnutrition guidance through its mobile application. Nourish works with registered dietitian nutritionists who provide support for conditions such as diabetes, weight management, cardiovascular health, eating disorders, and pediatric nutrition care. The company states that it partners with major insurance providers to reduce out-of-pocket costs for patients and offers ongoing nutritional care through recurring consultations. In addition to patient services, Nourish publishes educational resources and uses data-driven approaches to support personalized nutrition planning and long-term health management. | $8M / Seed / Feb 01, 2023 | |
Adonis
|
Adonis provides revenue cycle management software that improves data visibility and financial operations for healthcare organizations. It offers tools that aggregate billing, claims, and payment data into a unified platform to support analysis and workflow management. The company enables users to monitor revenue performance, identify discrepancies,and manage processes such as claim tracking and reimbursement analysis. Its platform integrates with existing healthcare systems to centralize financial data and streamline reporting activities. Adonis also delivers dashboards and automation features that assist teams in handling operational tasks related to billing and collections. | $5.6M / Seed / Oct 14, 2022 | |
Power Life Science
|
Power Life Science believes that every patient deserves the chance to participate in a life-changing clinical trial. Is backed by some of the best healthcare investors and operators with a range of experience across clinical research and biopharmaceuticals. We are a small team - each of us with our own personal story and motivation to make adifference in the lives of patients. | $7M / Seed / Aug 30, 2022 | |
Osmind
|
Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists to advance new evidence-based medicine that helps people living with moderate to severe mental health conditions. For more information, please visit osmind.org. | $40M / Series B / May 10, 2022 | |
Centaur Labs
|
Centaur offers a platform and services for expert data annotation. We provide unmatched accuracy and scale by harnessing the collective intelligence of a global network of tens of thousands of students and professionals who compete with each other to be the best data annotator. | $15M / Series A / Aug 17, 2021 | |
Alife
|
Alife develops artificial intelligence tools to assist physicians in increasing a patient's chances of pregnancy success. The company has a mission of helping people have healthy children and connects fertility specialists to patients to assists with IVF.Alife Health was founded in 2020 by Paxton Maeder-York and is headquartered in SanFrancisco, California, United States. | $9.5M / Seed / May 03, 2021 | |
|
Grata Health
|
Grata is an AI-enabled addiction treatment platform that pairs a virtual clinic (MAT, therapy, peer support) with software to triage, schedule, and support patients in under a minute. The patient app delivers continuous recovery touchpoints, and the EHR automates provider workflows and risk monitoring to improve retention and lower cost of care. | Seed |
Co-Investors
About Susa Ventures
Susa Ventures invests in pre-seed and seed rounds, backing companies at their earliest stages and beyond.
Susa Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chad Byers
Co-founder & General Partner
|
|||
Courtney Lipkin
Partner
|
|||
|
Derick En'Wezoh, MD
Healthcare and Tech Investor
|
|||
Hammad Aslam
Investor
|
|||
Kenny Joo
Head of Finance
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Derick En'Wezoh, MD invest in?
Derick En'Wezoh, MD invests primarily in Health Care, Artificial Intelligence and Medical startups, most often at Seed and Pre-Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Derick En'Wezoh, MD?
Public channels for Derick En'Wezoh, MD include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Derick En'Wezoh, MD last invest?
The most recent investment recorded for Derick En'Wezoh, MD closed in Sep 2025. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
